Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We Need a Dividend Announcement

I agree with that solution, though announcing a dividend plan at this stage is premature, as the revenues to support it are suspect ($3.4M from MMP last quarter for instance). Likely it would be viewed as gimmicky independent of some substantial changes on the licensing front. Don't you think?

I think cost cutting, combined with substantial cash reserve build up to show that they have the financial ability to fight infringers and possibly divesify long term, with some cash dedicated to share buybacks would all be necessary BEFORE any divvy anouncement / action plan if it's going to provide any SUSTAINABLE pps increase. Otherwise, I think the pps will be subject to amplified swings based on any legal, USPTO or other challenge associated with the MMP.

Share
New Message
Please login to post a reply